{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-25-000139","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.893480+00:00","generated_at":"2026-05-16T22:15:16.591326+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Elevance Health reaffirms FY2025 EPS guidance of $24.70 ($30.00 adj.) and 90.0% benefit expense ratio","bullets":["Full-year 2025 GAAP EPS expected ~$24.70, including ~$5.30/sh net unfavorable items.","Adjusted EPS guidance unchanged at ~$30.00 per diluted share.","Full-year 2025 benefit expense ratio reaffirmed at approximately 90.0%.","Reaffirmation reflects current view on market conditions, operational performance, and regulatory landscape.","Guidance does not include adjustment items beyond those reported in Q3 2025 earnings."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-25-000139","json":"https://secwatch.observer/filing/0001156039-25-000139.json","markdown":"https://secwatch.observer/filing/0001156039-25-000139.md","text":"https://secwatch.observer/filing/0001156039-25-000139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000139/0001156039-25-000139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000139/elv-20251110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:15:16.591326+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}